Agenda

8:30– 9:00       Registration and Breakfast

 

9:05– 9:15       Welcome and Introduction, University of Maryland - IBBR

Kevin Knapstein, Manager, Bioprocess Scale-Up Facility, Biotechnology Research and Education Program College Park

 

9:15– 9:45       Regulatory Landscape - Biosimilars Update

Lois Beaver, Director International Harmonization at Food & Drug Administration (Ret.) LAB Enterprises

               

9:45– 10:15     Vaccine Development - Leveraging New Selectivities to Optimize Purification Processes

Mark Snyder, PhD, R&D Applications Manager, Bio-Rad Laboratories       

 

10:15– 10:30   Break 

 

10:30– 11:00   From Antibodies to Viral Vectors – Commonalities and New Challenges in Purification

Amanda Zhang, Scientist II, Vector Core, RegenxBio

 

11:00– 11:30   HCD Detection and Viral Quantification, an Absolute Measurement, Using Droplet Digital PCR

Christian Overgaard, PhD, Field Application Specialist, Bio-Rad Laboratories

 

11:30– 12:45   Lunch and IBBR Walking Tour          

 

12:45– 1:15     Process Development: A Case Study with a Recombinant E. coli Protein 

Andrew Lees, PhD, Scientific Director, Fina Biosolutions, Associate Professor University of Maryland, School of Medicine  

 

1:15– 1:45       A New AEX Mixed-Mode Tool For Bioprocessing

Xuemei He, PhD, R&D Manager, Chromatography Chemistry, Bio-Rad Laboratories

 

1:45– 2:00       Break 

 

2:00– 2:30       An Overview of Viral Clearance Best Practices

Coral Fulton, Viral Clearance Study Director, Texcell- North America

 

2:30– 3:00       Strategies for Purifying Large Biomolecules

William H. Rushton, MS, Chromatography Support Scientist, Bio-Rad Laboratories

 

3:00– 4:30       Poster Session and Networking Reception